Medical Care
Global Anti-NeuN Antibody Market Research Report 2025
- May 12, 25
- ID: 234915
- Pages: 115
- Figures: 111
- Views: 12
The global market for Anti-NeuN Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
NeuN is a reported synonym of the human protein "RNA binding fox-1 homolog 3", encoded by the gene RBFOX3. The full protein is reported to be 312 amino acid residues in length. The NeuN antigen is a documented neuronal marker.
Growing patient base, launch of novel anti-neuronal antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue of the anti-neuronal antibody market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-NeuN Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-NeuN Antibody.
The Anti-NeuN Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-NeuN Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-NeuN Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GeneTex
Novus Biologicals
Bioss
United States Biological
Thermo Fisher Scientific
Biorbyt
Synaptic Systems GmbH
LifeSpan BioSciences
NSJ Bioreagents
EpiGentek
Cell Signaling Technology
G Biosciences
Abcam
HUABIO
Enzo Life Sciences
RayBiotech
Merck
Bio-Rad
RevMAb Biosciences
Miltenyi Biotec
Leading Biology
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunofluorescence (IF)
Immunochemistry (IHC)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-NeuN Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-NeuN Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
NeuN is a reported synonym of the human protein "RNA binding fox-1 homolog 3", encoded by the gene RBFOX3. The full protein is reported to be 312 amino acid residues in length. The NeuN antigen is a documented neuronal marker.
Growing patient base, launch of novel anti-neuronal antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue of the anti-neuronal antibody market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-NeuN Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-NeuN Antibody.
The Anti-NeuN Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-NeuN Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-NeuN Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GeneTex
Novus Biologicals
Bioss
United States Biological
Thermo Fisher Scientific
Biorbyt
Synaptic Systems GmbH
LifeSpan BioSciences
NSJ Bioreagents
EpiGentek
Cell Signaling Technology
G Biosciences
Abcam
HUABIO
Enzo Life Sciences
RayBiotech
Merck
Bio-Rad
RevMAb Biosciences
Miltenyi Biotec
Leading Biology
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunofluorescence (IF)
Immunochemistry (IHC)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-NeuN Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-NeuN Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Anti-NeuN Antibody Market Overview
1.1 Product Definition
1.2 Anti-NeuN Antibody by Type
1.2.1 Global Anti-NeuN Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Anti-NeuN Antibody by Application
1.3.1 Global Anti-NeuN Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunofluorescence (IF)
1.3.3 Immunochemistry (IHC)
1.3.4 Western Blot (WB)
1.3.5 ELISA
1.3.6 Others
1.4 Global Anti-NeuN Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-NeuN Antibody Revenue 2020-2031
1.4.2 Global Anti-NeuN Antibody Sales 2020-2031
1.4.3 Global Anti-NeuN Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-NeuN Antibody Market Competition by Manufacturers
2.1 Global Anti-NeuN Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-NeuN Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-NeuN Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-NeuN Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-NeuN Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-NeuN Antibody, Product Type & Application
2.7 Global Key Manufacturers of Anti-NeuN Antibody, Date of Enter into This Industry
2.8 Global Anti-NeuN Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-NeuN Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-NeuN Antibody Players Market Share by Revenue
2.8.3 Global Anti-NeuN Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-NeuN Antibody Market Scenario by Region
3.1 Global Anti-NeuN Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-NeuN Antibody Sales by Region: 2020-2031
3.2.1 Global Anti-NeuN Antibody Sales by Region: 2020-2025
3.2.2 Global Anti-NeuN Antibody Sales by Region: 2026-2031
3.3 Global Anti-NeuN Antibody Revenue by Region: 2020-2031
3.3.1 Global Anti-NeuN Antibody Revenue by Region: 2020-2025
3.3.2 Global Anti-NeuN Antibody Revenue by Region: 2026-2031
3.4 North America Anti-NeuN Antibody Market Facts & Figures by Country
3.4.1 North America Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-NeuN Antibody Sales by Country (2020-2031)
3.4.3 North America Anti-NeuN Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-NeuN Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-NeuN Antibody Sales by Country (2020-2031)
3.5.3 Europe Anti-NeuN Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-NeuN Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-NeuN Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-NeuN Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-NeuN Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-NeuN Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-NeuN Antibody Sales by Country (2020-2031)
3.7.3 Latin America Anti-NeuN Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-NeuN Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-NeuN Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-NeuN Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-NeuN Antibody Sales by Type (2020-2031)
4.1.1 Global Anti-NeuN Antibody Sales by Type (2020-2025)
4.1.2 Global Anti-NeuN Antibody Sales by Type (2026-2031)
4.1.3 Global Anti-NeuN Antibody Sales Market Share by Type (2020-2031)
4.2 Global Anti-NeuN Antibody Revenue by Type (2020-2031)
4.2.1 Global Anti-NeuN Antibody Revenue by Type (2020-2025)
4.2.2 Global Anti-NeuN Antibody Revenue by Type (2026-2031)
4.2.3 Global Anti-NeuN Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Anti-NeuN Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-NeuN Antibody Sales by Application (2020-2031)
5.1.1 Global Anti-NeuN Antibody Sales by Application (2020-2025)
5.1.2 Global Anti-NeuN Antibody Sales by Application (2026-2031)
5.1.3 Global Anti-NeuN Antibody Sales Market Share by Application (2020-2031)
5.2 Global Anti-NeuN Antibody Revenue by Application (2020-2031)
5.2.1 Global Anti-NeuN Antibody Revenue by Application (2020-2025)
5.2.2 Global Anti-NeuN Antibody Revenue by Application (2026-2031)
5.2.3 Global Anti-NeuN Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Anti-NeuN Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GeneTex
6.1.1 GeneTex Company Information
6.1.2 GeneTex Description and Business Overview
6.1.3 GeneTex Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GeneTex Anti-NeuN Antibody Product Portfolio
6.1.5 GeneTex Recent Developments/Updates
6.2 Novus Biologicals
6.2.1 Novus Biologicals Company Information
6.2.2 Novus Biologicals Description and Business Overview
6.2.3 Novus Biologicals Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novus Biologicals Anti-NeuN Antibody Product Portfolio
6.2.5 Novus Biologicals Recent Developments/Updates
6.3 Bioss
6.3.1 Bioss Company Information
6.3.2 Bioss Description and Business Overview
6.3.3 Bioss Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioss Anti-NeuN Antibody Product Portfolio
6.3.5 Bioss Recent Developments/Updates
6.4 United States Biological
6.4.1 United States Biological Company Information
6.4.2 United States Biological Description and Business Overview
6.4.3 United States Biological Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United States Biological Anti-NeuN Antibody Product Portfolio
6.4.5 United States Biological Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Thermo Fisher Scientific Anti-NeuN Antibody Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Biorbyt
6.6.1 Biorbyt Company Information
6.6.2 Biorbyt Description and Business Overview
6.6.3 Biorbyt Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biorbyt Anti-NeuN Antibody Product Portfolio
6.6.5 Biorbyt Recent Developments/Updates
6.7 Synaptic Systems GmbH
6.7.1 Synaptic Systems GmbH Company Information
6.7.2 Synaptic Systems GmbH Description and Business Overview
6.7.3 Synaptic Systems GmbH Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Synaptic Systems GmbH Anti-NeuN Antibody Product Portfolio
6.7.5 Synaptic Systems GmbH Recent Developments/Updates
6.8 LifeSpan BioSciences
6.8.1 LifeSpan BioSciences Company Information
6.8.2 LifeSpan BioSciences Description and Business Overview
6.8.3 LifeSpan BioSciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LifeSpan BioSciences Anti-NeuN Antibody Product Portfolio
6.8.5 LifeSpan BioSciences Recent Developments/Updates
6.9 NSJ Bioreagents
6.9.1 NSJ Bioreagents Company Information
6.9.2 NSJ Bioreagents Description and Business Overview
6.9.3 NSJ Bioreagents Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NSJ Bioreagents Anti-NeuN Antibody Product Portfolio
6.9.5 NSJ Bioreagents Recent Developments/Updates
6.10 EpiGentek
6.10.1 EpiGentek Company Information
6.10.2 EpiGentek Description and Business Overview
6.10.3 EpiGentek Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 EpiGentek Anti-NeuN Antibody Product Portfolio
6.10.5 EpiGentek Recent Developments/Updates
6.11 Cell Signaling Technology
6.11.1 Cell Signaling Technology Company Information
6.11.2 Cell Signaling Technology Description and Business Overview
6.11.3 Cell Signaling Technology Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cell Signaling Technology Anti-NeuN Antibody Product Portfolio
6.11.5 Cell Signaling Technology Recent Developments/Updates
6.12 G Biosciences
6.12.1 G Biosciences Company Information
6.12.2 G Biosciences Description and Business Overview
6.12.3 G Biosciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 G Biosciences Anti-NeuN Antibody Product Portfolio
6.12.5 G Biosciences Recent Developments/Updates
6.13 Abcam
6.13.1 Abcam Company Information
6.13.2 Abcam Description and Business Overview
6.13.3 Abcam Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abcam Anti-NeuN Antibody Product Portfolio
6.13.5 Abcam Recent Developments/Updates
6.14 HUABIO
6.14.1 HUABIO Company Information
6.14.2 HUABIO Description and Business Overview
6.14.3 HUABIO Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 HUABIO Anti-NeuN Antibody Product Portfolio
6.14.5 HUABIO Recent Developments/Updates
6.15 Enzo Life Sciences
6.15.1 Enzo Life Sciences Company Information
6.15.2 Enzo Life Sciences Description and Business Overview
6.15.3 Enzo Life Sciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Enzo Life Sciences Anti-NeuN Antibody Product Portfolio
6.15.5 Enzo Life Sciences Recent Developments/Updates
6.16 RayBiotech
6.16.1 RayBiotech Company Information
6.16.2 RayBiotech Description and Business Overview
6.16.3 RayBiotech Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 RayBiotech Anti-NeuN Antibody Product Portfolio
6.16.5 RayBiotech Recent Developments/Updates
6.17 Merck
6.17.1 Merck Company Information
6.17.2 Merck Description and Business Overview
6.17.3 Merck Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Merck Anti-NeuN Antibody Product Portfolio
6.17.5 Merck Recent Developments/Updates
6.18 Bio-Rad
6.18.1 Bio-Rad Company Information
6.18.2 Bio-Rad Description and Business Overview
6.18.3 Bio-Rad Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bio-Rad Anti-NeuN Antibody Product Portfolio
6.18.5 Bio-Rad Recent Developments/Updates
6.19 RevMAb Biosciences
6.19.1 RevMAb Biosciences Company Information
6.19.2 RevMAb Biosciences Description and Business Overview
6.19.3 RevMAb Biosciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 RevMAb Biosciences Anti-NeuN Antibody Product Portfolio
6.19.5 RevMAb Biosciences Recent Developments/Updates
6.20 Miltenyi Biotec
6.20.1 Miltenyi Biotec Company Information
6.20.2 Miltenyi Biotec Description and Business Overview
6.20.3 Miltenyi Biotec Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Miltenyi Biotec Anti-NeuN Antibody Product Portfolio
6.20.5 Miltenyi Biotec Recent Developments/Updates
6.21 Leading Biology
6.21.1 Leading Biology Company Information
6.21.2 Leading Biology Description and Business Overview
6.21.3 Leading Biology Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Leading Biology Anti-NeuN Antibody Product Portfolio
6.21.5 Leading Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-NeuN Antibody Industry Chain Analysis
7.2 Anti-NeuN Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-NeuN Antibody Production Mode & Process Analysis
7.4 Anti-NeuN Antibody Sales and Marketing
7.4.1 Anti-NeuN Antibody Sales Channels
7.4.2 Anti-NeuN Antibody Distributors
7.5 Anti-NeuN Antibody Customer Analysis
8 Anti-NeuN Antibody Market Dynamics
8.1 Anti-NeuN Antibody Industry Trends
8.2 Anti-NeuN Antibody Market Drivers
8.3 Anti-NeuN Antibody Market Challenges
8.4 Anti-NeuN Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Anti-NeuN Antibody by Type
1.2.1 Global Anti-NeuN Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Anti-NeuN Antibody by Application
1.3.1 Global Anti-NeuN Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunofluorescence (IF)
1.3.3 Immunochemistry (IHC)
1.3.4 Western Blot (WB)
1.3.5 ELISA
1.3.6 Others
1.4 Global Anti-NeuN Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-NeuN Antibody Revenue 2020-2031
1.4.2 Global Anti-NeuN Antibody Sales 2020-2031
1.4.3 Global Anti-NeuN Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-NeuN Antibody Market Competition by Manufacturers
2.1 Global Anti-NeuN Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-NeuN Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-NeuN Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-NeuN Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-NeuN Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-NeuN Antibody, Product Type & Application
2.7 Global Key Manufacturers of Anti-NeuN Antibody, Date of Enter into This Industry
2.8 Global Anti-NeuN Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-NeuN Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-NeuN Antibody Players Market Share by Revenue
2.8.3 Global Anti-NeuN Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-NeuN Antibody Market Scenario by Region
3.1 Global Anti-NeuN Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-NeuN Antibody Sales by Region: 2020-2031
3.2.1 Global Anti-NeuN Antibody Sales by Region: 2020-2025
3.2.2 Global Anti-NeuN Antibody Sales by Region: 2026-2031
3.3 Global Anti-NeuN Antibody Revenue by Region: 2020-2031
3.3.1 Global Anti-NeuN Antibody Revenue by Region: 2020-2025
3.3.2 Global Anti-NeuN Antibody Revenue by Region: 2026-2031
3.4 North America Anti-NeuN Antibody Market Facts & Figures by Country
3.4.1 North America Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-NeuN Antibody Sales by Country (2020-2031)
3.4.3 North America Anti-NeuN Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-NeuN Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-NeuN Antibody Sales by Country (2020-2031)
3.5.3 Europe Anti-NeuN Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-NeuN Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-NeuN Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-NeuN Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-NeuN Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-NeuN Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-NeuN Antibody Sales by Country (2020-2031)
3.7.3 Latin America Anti-NeuN Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-NeuN Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-NeuN Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-NeuN Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-NeuN Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-NeuN Antibody Sales by Type (2020-2031)
4.1.1 Global Anti-NeuN Antibody Sales by Type (2020-2025)
4.1.2 Global Anti-NeuN Antibody Sales by Type (2026-2031)
4.1.3 Global Anti-NeuN Antibody Sales Market Share by Type (2020-2031)
4.2 Global Anti-NeuN Antibody Revenue by Type (2020-2031)
4.2.1 Global Anti-NeuN Antibody Revenue by Type (2020-2025)
4.2.2 Global Anti-NeuN Antibody Revenue by Type (2026-2031)
4.2.3 Global Anti-NeuN Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Anti-NeuN Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-NeuN Antibody Sales by Application (2020-2031)
5.1.1 Global Anti-NeuN Antibody Sales by Application (2020-2025)
5.1.2 Global Anti-NeuN Antibody Sales by Application (2026-2031)
5.1.3 Global Anti-NeuN Antibody Sales Market Share by Application (2020-2031)
5.2 Global Anti-NeuN Antibody Revenue by Application (2020-2031)
5.2.1 Global Anti-NeuN Antibody Revenue by Application (2020-2025)
5.2.2 Global Anti-NeuN Antibody Revenue by Application (2026-2031)
5.2.3 Global Anti-NeuN Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Anti-NeuN Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GeneTex
6.1.1 GeneTex Company Information
6.1.2 GeneTex Description and Business Overview
6.1.3 GeneTex Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GeneTex Anti-NeuN Antibody Product Portfolio
6.1.5 GeneTex Recent Developments/Updates
6.2 Novus Biologicals
6.2.1 Novus Biologicals Company Information
6.2.2 Novus Biologicals Description and Business Overview
6.2.3 Novus Biologicals Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novus Biologicals Anti-NeuN Antibody Product Portfolio
6.2.5 Novus Biologicals Recent Developments/Updates
6.3 Bioss
6.3.1 Bioss Company Information
6.3.2 Bioss Description and Business Overview
6.3.3 Bioss Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioss Anti-NeuN Antibody Product Portfolio
6.3.5 Bioss Recent Developments/Updates
6.4 United States Biological
6.4.1 United States Biological Company Information
6.4.2 United States Biological Description and Business Overview
6.4.3 United States Biological Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United States Biological Anti-NeuN Antibody Product Portfolio
6.4.5 United States Biological Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Thermo Fisher Scientific Anti-NeuN Antibody Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Biorbyt
6.6.1 Biorbyt Company Information
6.6.2 Biorbyt Description and Business Overview
6.6.3 Biorbyt Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biorbyt Anti-NeuN Antibody Product Portfolio
6.6.5 Biorbyt Recent Developments/Updates
6.7 Synaptic Systems GmbH
6.7.1 Synaptic Systems GmbH Company Information
6.7.2 Synaptic Systems GmbH Description and Business Overview
6.7.3 Synaptic Systems GmbH Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Synaptic Systems GmbH Anti-NeuN Antibody Product Portfolio
6.7.5 Synaptic Systems GmbH Recent Developments/Updates
6.8 LifeSpan BioSciences
6.8.1 LifeSpan BioSciences Company Information
6.8.2 LifeSpan BioSciences Description and Business Overview
6.8.3 LifeSpan BioSciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LifeSpan BioSciences Anti-NeuN Antibody Product Portfolio
6.8.5 LifeSpan BioSciences Recent Developments/Updates
6.9 NSJ Bioreagents
6.9.1 NSJ Bioreagents Company Information
6.9.2 NSJ Bioreagents Description and Business Overview
6.9.3 NSJ Bioreagents Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NSJ Bioreagents Anti-NeuN Antibody Product Portfolio
6.9.5 NSJ Bioreagents Recent Developments/Updates
6.10 EpiGentek
6.10.1 EpiGentek Company Information
6.10.2 EpiGentek Description and Business Overview
6.10.3 EpiGentek Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 EpiGentek Anti-NeuN Antibody Product Portfolio
6.10.5 EpiGentek Recent Developments/Updates
6.11 Cell Signaling Technology
6.11.1 Cell Signaling Technology Company Information
6.11.2 Cell Signaling Technology Description and Business Overview
6.11.3 Cell Signaling Technology Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cell Signaling Technology Anti-NeuN Antibody Product Portfolio
6.11.5 Cell Signaling Technology Recent Developments/Updates
6.12 G Biosciences
6.12.1 G Biosciences Company Information
6.12.2 G Biosciences Description and Business Overview
6.12.3 G Biosciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 G Biosciences Anti-NeuN Antibody Product Portfolio
6.12.5 G Biosciences Recent Developments/Updates
6.13 Abcam
6.13.1 Abcam Company Information
6.13.2 Abcam Description and Business Overview
6.13.3 Abcam Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abcam Anti-NeuN Antibody Product Portfolio
6.13.5 Abcam Recent Developments/Updates
6.14 HUABIO
6.14.1 HUABIO Company Information
6.14.2 HUABIO Description and Business Overview
6.14.3 HUABIO Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 HUABIO Anti-NeuN Antibody Product Portfolio
6.14.5 HUABIO Recent Developments/Updates
6.15 Enzo Life Sciences
6.15.1 Enzo Life Sciences Company Information
6.15.2 Enzo Life Sciences Description and Business Overview
6.15.3 Enzo Life Sciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Enzo Life Sciences Anti-NeuN Antibody Product Portfolio
6.15.5 Enzo Life Sciences Recent Developments/Updates
6.16 RayBiotech
6.16.1 RayBiotech Company Information
6.16.2 RayBiotech Description and Business Overview
6.16.3 RayBiotech Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 RayBiotech Anti-NeuN Antibody Product Portfolio
6.16.5 RayBiotech Recent Developments/Updates
6.17 Merck
6.17.1 Merck Company Information
6.17.2 Merck Description and Business Overview
6.17.3 Merck Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Merck Anti-NeuN Antibody Product Portfolio
6.17.5 Merck Recent Developments/Updates
6.18 Bio-Rad
6.18.1 Bio-Rad Company Information
6.18.2 Bio-Rad Description and Business Overview
6.18.3 Bio-Rad Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bio-Rad Anti-NeuN Antibody Product Portfolio
6.18.5 Bio-Rad Recent Developments/Updates
6.19 RevMAb Biosciences
6.19.1 RevMAb Biosciences Company Information
6.19.2 RevMAb Biosciences Description and Business Overview
6.19.3 RevMAb Biosciences Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 RevMAb Biosciences Anti-NeuN Antibody Product Portfolio
6.19.5 RevMAb Biosciences Recent Developments/Updates
6.20 Miltenyi Biotec
6.20.1 Miltenyi Biotec Company Information
6.20.2 Miltenyi Biotec Description and Business Overview
6.20.3 Miltenyi Biotec Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Miltenyi Biotec Anti-NeuN Antibody Product Portfolio
6.20.5 Miltenyi Biotec Recent Developments/Updates
6.21 Leading Biology
6.21.1 Leading Biology Company Information
6.21.2 Leading Biology Description and Business Overview
6.21.3 Leading Biology Anti-NeuN Antibody Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Leading Biology Anti-NeuN Antibody Product Portfolio
6.21.5 Leading Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-NeuN Antibody Industry Chain Analysis
7.2 Anti-NeuN Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-NeuN Antibody Production Mode & Process Analysis
7.4 Anti-NeuN Antibody Sales and Marketing
7.4.1 Anti-NeuN Antibody Sales Channels
7.4.2 Anti-NeuN Antibody Distributors
7.5 Anti-NeuN Antibody Customer Analysis
8 Anti-NeuN Antibody Market Dynamics
8.1 Anti-NeuN Antibody Industry Trends
8.2 Anti-NeuN Antibody Market Drivers
8.3 Anti-NeuN Antibody Market Challenges
8.4 Anti-NeuN Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-NeuN Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-NeuN Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-NeuN Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-NeuN Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global Anti-NeuN Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-NeuN Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-NeuN Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-NeuN Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-NeuN Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-NeuN Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-NeuN Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Anti-NeuN Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-NeuN Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-NeuN Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-NeuN Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-NeuN Antibody Sales by Region (2020-2025) & (L)
Table 18. Global Anti-NeuN Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Anti-NeuN Antibody Sales by Region (2026-2031) & (L)
Table 20. Global Anti-NeuN Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Anti-NeuN Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-NeuN Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-NeuN Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-NeuN Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 27. North America Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 28. North America Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-NeuN Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-NeuN Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific Anti-NeuN Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific Anti-NeuN Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-NeuN Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-NeuN Antibody Sales (L) by Type (2020-2025)
Table 51. Global Anti-NeuN Antibody Sales (L) by Type (2026-2031)
Table 52. Global Anti-NeuN Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Anti-NeuN Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Anti-NeuN Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-NeuN Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-NeuN Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-NeuN Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-NeuN Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global Anti-NeuN Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global Anti-NeuN Antibody Sales (L) by Application (2020-2025)
Table 61. Global Anti-NeuN Antibody Sales (L) by Application (2026-2031)
Table 62. Global Anti-NeuN Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Anti-NeuN Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Anti-NeuN Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-NeuN Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-NeuN Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-NeuN Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-NeuN Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global Anti-NeuN Antibody Price (US$/L) by Application (2026-2031)
Table 70. GeneTex Company Information
Table 71. GeneTex Description and Business Overview
Table 72. GeneTex Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. GeneTex Anti-NeuN Antibody Product
Table 74. GeneTex Recent Developments/Updates
Table 75. Novus Biologicals Company Information
Table 76. Novus Biologicals Description and Business Overview
Table 77. Novus Biologicals Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Novus Biologicals Anti-NeuN Antibody Product
Table 79. Novus Biologicals Recent Developments/Updates
Table 80. Bioss Company Information
Table 81. Bioss Description and Business Overview
Table 82. Bioss Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Bioss Anti-NeuN Antibody Product
Table 84. Bioss Recent Developments/Updates
Table 85. United States Biological Company Information
Table 86. United States Biological Description and Business Overview
Table 87. United States Biological Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. United States Biological Anti-NeuN Antibody Product
Table 89. United States Biological Recent Developments/Updates
Table 90. Thermo Fisher Scientific Company Information
Table 91. Thermo Fisher Scientific Description and Business Overview
Table 92. Thermo Fisher Scientific Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. Thermo Fisher Scientific Anti-NeuN Antibody Product
Table 94. Thermo Fisher Scientific Recent Developments/Updates
Table 95. Biorbyt Company Information
Table 96. Biorbyt Description and Business Overview
Table 97. Biorbyt Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. Biorbyt Anti-NeuN Antibody Product
Table 99. Biorbyt Recent Developments/Updates
Table 100. Synaptic Systems GmbH Company Information
Table 101. Synaptic Systems GmbH Description and Business Overview
Table 102. Synaptic Systems GmbH Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. Synaptic Systems GmbH Anti-NeuN Antibody Product
Table 104. Synaptic Systems GmbH Recent Developments/Updates
Table 105. LifeSpan BioSciences Company Information
Table 106. LifeSpan BioSciences Description and Business Overview
Table 107. LifeSpan BioSciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. LifeSpan BioSciences Anti-NeuN Antibody Product
Table 109. LifeSpan BioSciences Recent Developments/Updates
Table 110. NSJ Bioreagents Company Information
Table 111. NSJ Bioreagents Description and Business Overview
Table 112. NSJ Bioreagents Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. NSJ Bioreagents Anti-NeuN Antibody Product
Table 114. NSJ Bioreagents Recent Developments/Updates
Table 115. EpiGentek Company Information
Table 116. EpiGentek Description and Business Overview
Table 117. EpiGentek Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. EpiGentek Anti-NeuN Antibody Product
Table 119. EpiGentek Recent Developments/Updates
Table 120. Cell Signaling Technology Company Information
Table 121. Cell Signaling Technology Description and Business Overview
Table 122. Cell Signaling Technology Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. Cell Signaling Technology Anti-NeuN Antibody Product
Table 124. Cell Signaling Technology Recent Developments/Updates
Table 125. G Biosciences Company Information
Table 126. G Biosciences Description and Business Overview
Table 127. G Biosciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. G Biosciences Anti-NeuN Antibody Product
Table 129. G Biosciences Recent Developments/Updates
Table 130. Abcam Company Information
Table 131. Abcam Description and Business Overview
Table 132. Abcam Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. Abcam Anti-NeuN Antibody Product
Table 134. Abcam Recent Developments/Updates
Table 135. HUABIO Company Information
Table 136. HUABIO Description and Business Overview
Table 137. HUABIO Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. HUABIO Anti-NeuN Antibody Product
Table 139. HUABIO Recent Developments/Updates
Table 140. Enzo Life Sciences Company Information
Table 141. Enzo Life Sciences Description and Business Overview
Table 142. Enzo Life Sciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. Enzo Life Sciences Anti-NeuN Antibody Product
Table 144. Enzo Life Sciences Recent Developments/Updates
Table 145. RayBiotech Company Information
Table 146. RayBiotech Description and Business Overview
Table 147. RayBiotech Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. RayBiotech Anti-NeuN Antibody Product
Table 149. RayBiotech Recent Developments/Updates
Table 150. Merck Company Information
Table 151. Merck Description and Business Overview
Table 152. Merck Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. Merck Anti-NeuN Antibody Product
Table 154. Merck Recent Developments/Updates
Table 155. Bio-Rad Company Information
Table 156. Bio-Rad Description and Business Overview
Table 157. Bio-Rad Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. Bio-Rad Anti-NeuN Antibody Product
Table 159. Bio-Rad Recent Developments/Updates
Table 160. RevMAb Biosciences Company Information
Table 161. RevMAb Biosciences Description and Business Overview
Table 162. RevMAb Biosciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. RevMAb Biosciences Anti-NeuN Antibody Product
Table 164. RevMAb Biosciences Recent Developments/Updates
Table 165. Miltenyi Biotec Company Information
Table 166. Miltenyi Biotec Description and Business Overview
Table 167. Miltenyi Biotec Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 168. Miltenyi Biotec Anti-NeuN Antibody Product
Table 169. Miltenyi Biotec Recent Developments/Updates
Table 170. Leading Biology Company Information
Table 171. Leading Biology Description and Business Overview
Table 172. Leading Biology Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 173. Leading Biology Anti-NeuN Antibody Product
Table 174. Leading Biology Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Anti-NeuN Antibody Distributors List
Table 178. Anti-NeuN Antibody Customers List
Table 179. Anti-NeuN Antibody Market Trends
Table 180. Anti-NeuN Antibody Market Drivers
Table 181. Anti-NeuN Antibody Market Challenges
Table 182. Anti-NeuN Antibody Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-NeuN Antibody
Figure 2. Global Anti-NeuN Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-NeuN Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global Anti-NeuN Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-NeuN Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunofluorescence (IF)
Figure 9. Immunochemistry (IHC)
Figure 10. Western Blot (WB)
Figure 11. ELISA
Figure 12. Others
Figure 13. Global Anti-NeuN Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Anti-NeuN Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global Anti-NeuN Antibody Sales (2020-2031) & (L)
Figure 16. Global Anti-NeuN Antibody Average Price (US$/L) & (2020-2031)
Figure 17. Anti-NeuN Antibody Report Years Considered
Figure 18. Anti-NeuN Antibody Sales Share by Manufacturers in 2024
Figure 19. Global Anti-NeuN Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Anti-NeuN Antibody Players: Market Share by Revenue in Anti-NeuN Antibody in 2024
Figure 21. Anti-NeuN Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Anti-NeuN Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 25. United States Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Anti-NeuN Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Anti-NeuN Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Anti-NeuN Antibody by Type (2020-2031)
Figure 54. Global Revenue Market Share of Anti-NeuN Antibody by Type (2020-2031)
Figure 55. Global Anti-NeuN Antibody Price (US$/L) by Type (2020-2031)
Figure 56. Global Sales Market Share of Anti-NeuN Antibody by Application (2020-2031)
Figure 57. Global Revenue Market Share of Anti-NeuN Antibody by Application (2020-2031)
Figure 58. Global Anti-NeuN Antibody Price (US$/L) by Application (2020-2031)
Figure 59. Anti-NeuN Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Anti-NeuN Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-NeuN Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-NeuN Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-NeuN Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global Anti-NeuN Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-NeuN Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-NeuN Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-NeuN Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-NeuN Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-NeuN Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-NeuN Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Anti-NeuN Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-NeuN Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-NeuN Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-NeuN Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-NeuN Antibody Sales by Region (2020-2025) & (L)
Table 18. Global Anti-NeuN Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Anti-NeuN Antibody Sales by Region (2026-2031) & (L)
Table 20. Global Anti-NeuN Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Anti-NeuN Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-NeuN Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-NeuN Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-NeuN Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 27. North America Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 28. North America Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-NeuN Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-NeuN Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific Anti-NeuN Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific Anti-NeuN Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-NeuN Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-NeuN Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-NeuN Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa Anti-NeuN Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa Anti-NeuN Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-NeuN Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-NeuN Antibody Sales (L) by Type (2020-2025)
Table 51. Global Anti-NeuN Antibody Sales (L) by Type (2026-2031)
Table 52. Global Anti-NeuN Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Anti-NeuN Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Anti-NeuN Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-NeuN Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-NeuN Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-NeuN Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-NeuN Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global Anti-NeuN Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global Anti-NeuN Antibody Sales (L) by Application (2020-2025)
Table 61. Global Anti-NeuN Antibody Sales (L) by Application (2026-2031)
Table 62. Global Anti-NeuN Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Anti-NeuN Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Anti-NeuN Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-NeuN Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-NeuN Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-NeuN Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-NeuN Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global Anti-NeuN Antibody Price (US$/L) by Application (2026-2031)
Table 70. GeneTex Company Information
Table 71. GeneTex Description and Business Overview
Table 72. GeneTex Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. GeneTex Anti-NeuN Antibody Product
Table 74. GeneTex Recent Developments/Updates
Table 75. Novus Biologicals Company Information
Table 76. Novus Biologicals Description and Business Overview
Table 77. Novus Biologicals Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Novus Biologicals Anti-NeuN Antibody Product
Table 79. Novus Biologicals Recent Developments/Updates
Table 80. Bioss Company Information
Table 81. Bioss Description and Business Overview
Table 82. Bioss Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Bioss Anti-NeuN Antibody Product
Table 84. Bioss Recent Developments/Updates
Table 85. United States Biological Company Information
Table 86. United States Biological Description and Business Overview
Table 87. United States Biological Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. United States Biological Anti-NeuN Antibody Product
Table 89. United States Biological Recent Developments/Updates
Table 90. Thermo Fisher Scientific Company Information
Table 91. Thermo Fisher Scientific Description and Business Overview
Table 92. Thermo Fisher Scientific Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. Thermo Fisher Scientific Anti-NeuN Antibody Product
Table 94. Thermo Fisher Scientific Recent Developments/Updates
Table 95. Biorbyt Company Information
Table 96. Biorbyt Description and Business Overview
Table 97. Biorbyt Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. Biorbyt Anti-NeuN Antibody Product
Table 99. Biorbyt Recent Developments/Updates
Table 100. Synaptic Systems GmbH Company Information
Table 101. Synaptic Systems GmbH Description and Business Overview
Table 102. Synaptic Systems GmbH Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. Synaptic Systems GmbH Anti-NeuN Antibody Product
Table 104. Synaptic Systems GmbH Recent Developments/Updates
Table 105. LifeSpan BioSciences Company Information
Table 106. LifeSpan BioSciences Description and Business Overview
Table 107. LifeSpan BioSciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. LifeSpan BioSciences Anti-NeuN Antibody Product
Table 109. LifeSpan BioSciences Recent Developments/Updates
Table 110. NSJ Bioreagents Company Information
Table 111. NSJ Bioreagents Description and Business Overview
Table 112. NSJ Bioreagents Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. NSJ Bioreagents Anti-NeuN Antibody Product
Table 114. NSJ Bioreagents Recent Developments/Updates
Table 115. EpiGentek Company Information
Table 116. EpiGentek Description and Business Overview
Table 117. EpiGentek Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. EpiGentek Anti-NeuN Antibody Product
Table 119. EpiGentek Recent Developments/Updates
Table 120. Cell Signaling Technology Company Information
Table 121. Cell Signaling Technology Description and Business Overview
Table 122. Cell Signaling Technology Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. Cell Signaling Technology Anti-NeuN Antibody Product
Table 124. Cell Signaling Technology Recent Developments/Updates
Table 125. G Biosciences Company Information
Table 126. G Biosciences Description and Business Overview
Table 127. G Biosciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. G Biosciences Anti-NeuN Antibody Product
Table 129. G Biosciences Recent Developments/Updates
Table 130. Abcam Company Information
Table 131. Abcam Description and Business Overview
Table 132. Abcam Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. Abcam Anti-NeuN Antibody Product
Table 134. Abcam Recent Developments/Updates
Table 135. HUABIO Company Information
Table 136. HUABIO Description and Business Overview
Table 137. HUABIO Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. HUABIO Anti-NeuN Antibody Product
Table 139. HUABIO Recent Developments/Updates
Table 140. Enzo Life Sciences Company Information
Table 141. Enzo Life Sciences Description and Business Overview
Table 142. Enzo Life Sciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. Enzo Life Sciences Anti-NeuN Antibody Product
Table 144. Enzo Life Sciences Recent Developments/Updates
Table 145. RayBiotech Company Information
Table 146. RayBiotech Description and Business Overview
Table 147. RayBiotech Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. RayBiotech Anti-NeuN Antibody Product
Table 149. RayBiotech Recent Developments/Updates
Table 150. Merck Company Information
Table 151. Merck Description and Business Overview
Table 152. Merck Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. Merck Anti-NeuN Antibody Product
Table 154. Merck Recent Developments/Updates
Table 155. Bio-Rad Company Information
Table 156. Bio-Rad Description and Business Overview
Table 157. Bio-Rad Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. Bio-Rad Anti-NeuN Antibody Product
Table 159. Bio-Rad Recent Developments/Updates
Table 160. RevMAb Biosciences Company Information
Table 161. RevMAb Biosciences Description and Business Overview
Table 162. RevMAb Biosciences Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. RevMAb Biosciences Anti-NeuN Antibody Product
Table 164. RevMAb Biosciences Recent Developments/Updates
Table 165. Miltenyi Biotec Company Information
Table 166. Miltenyi Biotec Description and Business Overview
Table 167. Miltenyi Biotec Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 168. Miltenyi Biotec Anti-NeuN Antibody Product
Table 169. Miltenyi Biotec Recent Developments/Updates
Table 170. Leading Biology Company Information
Table 171. Leading Biology Description and Business Overview
Table 172. Leading Biology Anti-NeuN Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 173. Leading Biology Anti-NeuN Antibody Product
Table 174. Leading Biology Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Anti-NeuN Antibody Distributors List
Table 178. Anti-NeuN Antibody Customers List
Table 179. Anti-NeuN Antibody Market Trends
Table 180. Anti-NeuN Antibody Market Drivers
Table 181. Anti-NeuN Antibody Market Challenges
Table 182. Anti-NeuN Antibody Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-NeuN Antibody
Figure 2. Global Anti-NeuN Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-NeuN Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global Anti-NeuN Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-NeuN Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunofluorescence (IF)
Figure 9. Immunochemistry (IHC)
Figure 10. Western Blot (WB)
Figure 11. ELISA
Figure 12. Others
Figure 13. Global Anti-NeuN Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Anti-NeuN Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global Anti-NeuN Antibody Sales (2020-2031) & (L)
Figure 16. Global Anti-NeuN Antibody Average Price (US$/L) & (2020-2031)
Figure 17. Anti-NeuN Antibody Report Years Considered
Figure 18. Anti-NeuN Antibody Sales Share by Manufacturers in 2024
Figure 19. Global Anti-NeuN Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Anti-NeuN Antibody Players: Market Share by Revenue in Anti-NeuN Antibody in 2024
Figure 21. Anti-NeuN Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Anti-NeuN Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 25. United States Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Anti-NeuN Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Anti-NeuN Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Anti-NeuN Antibody Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Anti-NeuN Antibody Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Anti-NeuN Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Anti-NeuN Antibody by Type (2020-2031)
Figure 54. Global Revenue Market Share of Anti-NeuN Antibody by Type (2020-2031)
Figure 55. Global Anti-NeuN Antibody Price (US$/L) by Type (2020-2031)
Figure 56. Global Sales Market Share of Anti-NeuN Antibody by Application (2020-2031)
Figure 57. Global Revenue Market Share of Anti-NeuN Antibody by Application (2020-2031)
Figure 58. Global Anti-NeuN Antibody Price (US$/L) by Application (2020-2031)
Figure 59. Anti-NeuN Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232